• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Community-Acquired Respiratory Co-infection (CARC) in Critically Ill Patients Infected With Pandemic 2009 Influenza A (H1N1) Virus Infection

tetano

Editor, Senior Moderator
Chest. 2010 Oct 7. [Epub ahead of print]
Community-Acquired Respiratory Co-infection (CARC) in Critically Ill Patients Infected With Pandemic 2009 Influenza A (H1N1) Virus Infection.

Mart?n-Loeches I, Sanchez-Corral A, Diaz E, Granada R, Zaragoza R, Villavicencio C, Albaya A, Cerd? E, Catal?n R, Luque P, Paredes A, Navarrete I, Rello J, Rodr?guez A; H1N1 SEMICYUC Working Group.

(1)Critical Care Department. Joan XXIII University Hospital, University Rovira i Virgili, IISPV, CIBER Enfermedades Respiratorias (CIBERes) Tarragona, Spain.
Abstract

ABSTRACT

BACKGROUND: Little is known about the impact of Community-Acquired Respiratory Co-infection in patients with Pandemic 2009 Influenza A (H1N1) Virus Infection.

METHODS: Prospective, observational, multi-center study conducted in 148 Spanish ICU.

RESULTS: Severe respiratory syndrome was present in 645 ICU patients. Co-infection occurred in 113 (17.5%) of patients. S. pneumoniae 62 (54.8%) was identified as the most prevalent bacteria. Patients with co-infection were older (47.5 +/- 15.7 vs. 43.8 +/- 14.2 years, P < 0.05), presented a higher APACHE II score (16.1 +/- 7.3 vs. 13.3+/- 7.1, P < 0.05) and SOFA score (7.0 +/- 3.8 vs. 5.2+/- 3.5, P < 0.05) at ICU admission. No differences in comorbidities were observed. Patients who had co-infection required vasopressors (63.7% vs.39.3%, p<0.05) and invasive mechanical ventilation (69% vs.58.5%, p<0.05) more frequently. ICU-LOS was 3 days longer in patients who had co-infection compared to patients who did not (11 (IQR ,5-23) vs 8(IQR 4-17), p = 0.01). Co-infection was associated with increased ICU-mortality (26.2% vs.15.5%; OR= 1.94; 95% CI, 1.21-3.09), but Cox regression analysis adjusted by potential confounders did not confirm a significant association between co-infection and ICU-mortality.

CONCLUSIONS: During 2009 pandemics, the role of bacterial coinfection in bringing patients to the ICU has not been clear, being S. pneumoniae the most common pathogen. This work clearly evidences that bacterial coinfection is a contributor for increased consumption of health resources in critical patients infected with the virus, but is the virus the cause of critical illness in the vast majority of the cases.

PMID: 20930007 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/20930007
 
Back
Top Bottom